Placenta removal -- a safer method after Caesareans

July 16, 2008

In Caesarean deliveries the placenta is usually removed by hand or by a technique known as 'cord traction'. A recent systematic review by Cochrane Researchers shows that cord traction poses less risk to the mother than manual removal.

Removal of the placenta in Caesarean births may affect a woman's chance of complications such as endometritis (infection of lining of the womb) and post-operative bleeding. One possible cause of endometritis is that bacteria on the surgeon's gloves are carried into the womb during manual removal of the placenta.

In cord traction, the surgeon's hand doesn't enter the womb. Instead the woman is given oxytocin and external massage, which detach the placenta and it is then pulled from the womb by gentle traction on the umbilical cord.

The new study compares the advantages of the two techniques. Researchers reviewed 15 trials involving a total of 4,694 women and found that there was an increased risk of endometritis and high blood loss in caesareans where the placenta was removed by hand. Women who had manual removal also stayed in hospital longer after their operations.

"Although cord traction may take a little bit longer, there are clear health benefits of this method over manual removal of the placenta," says lead researcher Rose Anorlu, a gynaecologist at the College of Medicine of the University of Lagos in Nigeria.

Source: Wiley


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 5 /5 (1 vote)


July 16, 2008 all stories

Comments: 0

5 /5 (1 vote)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories

  • New and improved tomato analyzer
    created May 04, 2009 | popularity not rated yet | comments 0
  • Ultrasound enhances noninvasive Down syndrome tests
    created Nov 20, 2009 | popularity not rated yet | comments 0
  • Researchers find two units of umbilical cord blood reduce risk of leukemia recurrence
    created Nov 13, 2009 | popularity not rated yet | comments 0
  • Nanoparticles may cause DNA damage across a cellular barrier
    created Nov 05, 2009 | popularity not rated yet | comments 0
  • Lessons from flu seasons past
    created Oct 29, 2009 | popularity not rated yet | comments 0



  • hide
  • Relevant PhysicsForums posts

Other News

New cancer target for non-Hodgkin's lymphoma

Medicine & Health / Cancer

created 6 hours ago | popularity 5 / 5 (1) | comments 0

Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, ...


Surface bacteria maintain skin's healthy balance

Medicine & Health / Research

created 7 hours ago | popularity 5 / 5 (3) | comments 0

On the skin's surface, bacteria are abundant, diverse and constant, but inflammation is undesirable. Research at the University of California, San Diego School of Medicine now shows that the normal bacteria living on the ...


Gene mismatch influences success of bone marrow transplants

Medicine & Health / Genetics

created 7 hours ago | popularity not rated yet | comments 0

A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Ge ...


New understanding about mechanism for cell death after stroke leads to possible therapy

Medicine & Health / Research

created 7 hours ago | popularity not rated yet | comments 0

Scientists at the Brain Research Centre, a partnership of the University of British Columbia Faculty of Medicine and Vancouver Coastal Health Research Institute, have uncovered new information about the mechanism by which ...


Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer

Medicine & Health / Cancer

created 7 hours ago | popularity not rated yet | comments 0

Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. This breakthrough ...